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Unplanned readmission of patients remains a significant contributor 
to healthcare costs worldwide. It also further exposes the patient 
to hospital pathogens and potential additional procedures with 
associated complications. Globally, readmission rates vary from 10% 
to 25%, depending on the criteria used.[1]
A hospital readmission occurs when a patient who has been 
discharged from a hospital is admitted again within a specified time 
interval. Readmission rates have increasingly been used as an outcome 
measure in health services research and as a quality benchmark for 
health systems.[2] These unplanned readmissions are multifactorial, 
and causes are both preventable and non-preventable. They can be 
influenced by factors inherent to the specific healthcare system and can 
be an important measure of a medical system’s efficacy.[3] 
Various risk assessment tools are available to assess whether 
a patient is ready for discharge, the overall risk of mortality, and 
the risk of 30-day readmission. These tools stratify patients into 
categories depending on the extent of comorbidities and include 
the LACE score, the LACE+ score, the PRA score (Probability of 
Repeated Admission), GAP (General Assessment of Preparedness) 
and the BOOST model.[4-6]
Approximately 73% of the population of the Western Cape 
Province, South Africa (SA), is dependent on public sector 
healthcare. This figure reflects national health demographics. Owing 
to socioeconomic challenges, the government is unable to provide 
adequately for this population, leading to inadequate hospital bed 
numbers, premature discharge, and poor follow-up and palliative 
services after discharge.
Objectives
Patients readmitted to the Department of Internal Medicine at 
Tygerberg Academic Hospital (TBH), Cape Town, within 30 days 
of discharge were assessed. Characteristics of preventable and 
unpreventable readmissions were compared and potentially avoidable 
factors were identified. We sought to identify readmissions that were 
potentially avoidable, defined as preventable by a change in clinical 
decision‐making by a clinician under the current standard of care.
The performance of validated risk-stratification tools (the LACE 
index and modified LACE (mLACE) index, Table 1) was reviewed to 
assess their effectiveness in the TBH system.
Methods
A retrospective descriptive analysis of all patients readmitted to 
the Department of Internal Medicine at TBH within 30 days of 
discharge from 1 January 2014 to 31 March 2015 was done. A period 
of 14 months was used to increase the number of cases and augment 
the validity of the study.
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Objectives. To investigate possible preventable and non-preventable factors contributing to readmissions to the Department of Internal 
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rate of 10.5%. The majority of patients (66%) were readmitted within 14 days after discharge. The most important risk factor for readmission 
was the number of comorbidities, assessed using the Charlston score. The study also identified a large burden of potentially avoidable causes 
(35% of readmissions) due to system-related issues, premature discharge being the most common. Other reasons for 30-day readmission 
were nosocomial infection, adverse drug reactions, especially warfarin toxicity, inadequate discharge planning and physician error.
Conclusions. Despite TBH being a low-resource, high-turnover system, the 30-day readmission rate was calculated at 10.5%. Global 
readmission rates vary from 10% to 25%, depending on the reference article/source used. We found that 35% of 30-day readmissions were 
potentially avoidable. Venous thromboembolism was a minor contributor to readmission but was associated with a very high mortality 
rate. A secondary outcome evaluated was the utility of the LACE and modified LACE (mLACE) index in the TBH environment. The risk 
tool performed well in the TBH population, and a high LACE and mLACE score correlated with an increased risk of 30-day readmission 
(p<0.001).
S Afr Med J 2019;109(3):164-168. DOI:10.7196/SAMJ.2019.v109i3.13367
165       March 2019, Vol. 109, No. 3
RESEARCH
Data were captured and potential contributing factors were assessed. 
These were grouped into five categories indicating the reason for 
readmission, as follows: (i) discharge-related factors (premature 
discharge or inadequate discharge planning); (ii) disease progression; 
(iii) patient-related factors (non-adherence, poor social support); 
(iv) adverse events (healthcare-associated infections, thromboembolic 
diseases, physician errors, adverse drug reactions (ADRs)); and 
(v) system-related failure (lack of access to information or counselling). 
Since readmissions may be multifactorial, depending on whether the 
reviewing physician considered the factor a major contributor, more 
than one factor could be documented. Once the contributing factors 
had been assessed, readmitted cases were grouped into readmissions 
that were potentially preventable or unpreventable.
Patient demographics were assessed in terms of comorbidity 
prevalence, prevalence of HIV, length of stay (LoS), days since 
discharge, causes for readmission within 30 days, and whether 
admissions were potentially avoidable (deemed preventable) v. 
deemed not to be preventable.
Inclusion and exclusion criteria
All adult patients admitted to the Department of Internal Medi cine 
and living in the TBH district health system (DHS) drainage area 
were assessed. To prevent selection bias, patients living outside the 
TBH DHS area were excluded from the study. This was because TBH 
acts as both a primary and a referral hospital, so patients living in 
an area served by a referring hospital may primarily be readmitted 
to their local hospital. For this reason, their inclusion could have 
caused lost records and bias. Patients admitted for delivery and for 
elective procedures such as transplants, chemotherapy and surgical 
procedures were also excluded.
Data collection
Using the TBH electronic patient management system, the records of 
patients readmitted within 30 days were identified and perused and 
a database indicating the reasons for admission, comorbidities and 
potential avoidable and unavoidable risk factors was created. Causes 
of readmission were clearly defined.
Finally, the medical records of all readmissions deemed preventable 
were reviewed to determine how the readmission might have been 
prevented, and the results were tabulated. This method of assessment 
was developed to indicate preventability based on independent 
review by the researchers.
Ethical considerations
The study was approved by the Health Research Ethics Committee 
at Stellenbosch University and TBH (ref. no. S15/07/157). All patient 
identification was removed for the purposes of confidentiality.
Statistical analysis
SPSS Statistics for Windows, version 24.0 (IBM, USA) was used 
to analyse the data. Descriptive comparisons of three patient 
groups (Table 2) involved reporting of frequency counts and group 
percentages for categorical variables. Pearson’s χ2 test was applied to 
assess associations between the LACE and mLACE score categories 
and the three groups of patients. A p-value <0.05 was considered 
statistically significant.
Table 1. Modified LACE score tool[5,6]
Attribute Value Points
Prior admission LoS (days)
If no history of prior admission, give points 
for average LoS, i.e. 4 - 6 days
<1 0
1 1
2 2
3 3
4 - 6 4
7 - 13 5
≥14 6
Acute admission Inpatient 3
Observation 0
Comorbidity (cumulative to a
a maximum of 6 points)
No prior history 0
DM no complications, cerebrovascular disease, Hx of MI, PVD, PUD, alcoholism, 
smoking
1
Mild liver disease, DM with complications, CCF, COPD, cancer, leukaemia, 
lymphoma, any tumour, renal disease
2
Alzheimer’s disease, dementia, sickle cell disease, autoimmune disorder, connective 
tissue disease
3
Cirrhosis, hepatitis, liver disease, HIV infection 4
Metastatic cancer 6
Emergency room visits (n) during previous 
6 months
0 0
1 1
2 2
3 3
≥4 4
Take the sum of the points and enter the total. If the mLACE score is ≥11, the patient is at high risk for 30-day readmission after hospital 
discharge.
LoS = length of stay; DM = diabetes mellitus; Hx = history; MI = myocardial infarction; PVD = peripheral vascular disease; PUD = peptic ulcer disease; CCF = congestive cardiac failure;  
COPD = chronic obstructive pulmonary disease; mLACE = modified LACE. 
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Results
A total of 11 826 medical admissions were recorded during the study 
period. Of these patients, 1 242 were readmitted within a 30-day 
period, giving a readmission rate of 10.5%. The 1 242 patients 
were then divided into two categories, namely patients who lived 
in the TBH DHS drainage area and those who did not. A total of 
472 patients readmitted within 30 days lived in the designated area. 
Of these, 7 were excluded owing to missing medical records.
The records of the remaining 465 patients were scrutinised 
to determine whether the two admissions (index admission 
and readmission) were related or unrelated. After analysing the 
readmission diagnoses and attempting to find a causal relationship 
between the two admissions, 13% (n=59) of readmissions were 
classified as unrelated and the remaining 87% (n=406) as related, 
according to the predefined criteria listed in Table 2. A third group 
(the control group) was obtained by drawing a random sample of 
patients without a 30-day readmission for the same time period 
(Table 2).
The gender distribution was similar in the three groups. In both 
readmitted groups, the majority of patients (>71.5%) were aged 
<65 years. It is cause for concern that 39% of patients in the related 
readmissions group and 40% in the unrelated readmissions group 
were aged <50 years.
The prevalence of patient comorbidities in the related readmissions 
group was significantly higher than in the control group. However, 
there was a significantly  higher prevalence of respiratory diseases 
in the control group. This could be because they were randomly 
assigned as participants in the study and were therefore not matched 
for demographics beforehand.
Comorbidities included chronic obstructive pulmonary disease 
(COPD), asthma, bronchiectasis and post-tuberculosis (TB) 
structural lung disease. The latter could be explained by the high 
TB burden in the Western Cape. Hypertension, diabetes, renal 
impairment and cardiovascular system diseases other than those 
listed above were the most common comorbidities among patients 
with a 30-day readmission. Smoking and alcohol use were similar in 
the three groups, in all of which their prevalence was high. No illicit 
substances were investigated.
In both the readmitted groups, most patients (66%) were readmitted 
within 14 days from the index admission.
On categorising causes of readmission, it was evident that almost 
40% of patients were readmitted due to progression of their disease. 
This is an unavoidable cause, especially with chronic deteriorating 
diseases such as COPD and congestive cardiac failure (CCF).
The most prevalent diseases in the index admission that led to 
related readmission were cardiac failure, infections, COPD, cancer 
and cerebrovascular accidents (CVAs). Of the 406 patients with a 
related readmission, 246 (61%) were readmitted a second time. In this 
group the diagnoses in the second admission were similar to those in 
the first, except for ADRs, the rate of which was much higher.
In the unrelated admissions group, infections were the most 
common initial presenting diagnosis, followed by minor complaints, 
cardiac failure and CVAs. The most common readmission diagnoses 
in this group were TB, renal failure, overdoses and CVAs. CVAs were 
more prevalent in the control group than in the two readmissions 
groups.
The control group had a much higher prevalence of infections 
than the two readmissions groups. This makes sense given the fact 
that infections, once diagnosed and treated, should strictly speaking 
not lead to readmission. The rate of TB was also higher in the control 
group than in the other two groups. However, TB was the sixth most 
common diagnosis leading to readmission, possibly reflecting the 
chronic nature of this disease.
There was no marked difference in LoS between the readmitted 
patients and those in the control group. However, patients diagnosed 
with certain conditions such as CCF and COPD, which frequently led 
to readmission, tended to have a relatively short LoS compared with 
the control group (median 3 days v. 4 days). Other chronic conditions 
such as liver disease and renal disease had a LoS of ≥5 days, and for 
connective tissue diseases LoS was up to 12 days.
When evaluating potentially avoidable causes for 30-day 
readmission, the biggest contributor was premature discharge (10%), 
followed by inadequate discharge planning (7%), physician-related 
errors (5%) and ADRs and nosocomial infections (4%).
We identified 33 ADRs, of which 19 were deemed potentially 
avoidable. Seventeen of these patients had warfarin toxicity. It was 
perturbing that 6 of these 17 patients presented with warfarin toxicity 
at both the index admission and the readmission. One patient had a 
recorded international normalised ratio >4.5 on the day of discharge. 
The records did not specify whether this result was acted on by the 
discharging clinician.
In the study, non-compliance and socioeconomic factors were 
classified as unavoidable, as they are factors that physicians may 
struggle to change. Although education is imperative to minimise 
the risk of non-compliance, this responsibility remains the patient’s.
Non-compliance was responsible for almost 10% of readmissions, 
and lack of social support for 6%. A potential caveat regarding the 
non-compliance rate is the fact that most patients are discharged 
from hospital with a 1-month supply of chronic medication. If the 
readmission period had been longer, the non-compliance rate might 
have been higher, but further research in this area needs to be done.
Challenges surrounding palliative care and social support should 
be brought to the attention of the relevant department, which could 
attempt to address these socioeconomic issues.
On assessing the performance of the risk scores in the population 
studied, there was a strong association between readmission and 
severity score for both the LACE (p<0.001 and mLACE indices 
(p<0.001), indicating that both LACE and mLACE  may be useful 
tools in risk stratification of the TBH population.
There was a clear trend towards a higher LACE score (>10 – 
see Table 1) in the readmitted groups, with 59% of the related 
readmissions presenting a high risk (score >10) v. only 35% of the 
control group.
We studied the prevalence of HIV in all the groups. A cause for 
concern is that there was a very low uptake of HIV screening. In 
91.4% (n=371) of all related readmissions, a HIV test was not done at 
Table 2. Summary of the three patient groups
Related readmissions group (n=406) Patients readmitted to TBH within 30 days of discharge from hospital. The two admissions were 
assessed to be related to each other
Unrelated readmissions group (n=59) Patients readmitted to TBH within 30 days of discharge. The two admissions were assessed not to be 
related and no causal link could be found
Control group (n=346) Control group selected from patients admitted to TBH and not readmitted within 30 days of 
discharge
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either of the admissions. This fact was validated through reviewing all 
databases, including medical and National Health Laboratory Service 
records and referral letters. Given the high prevalence of HIV in SA, 
this issue needs urgent attention.
Discussion
Reducing hospital readmissions is a focus of healthcare systems 
worldwide in efforts to improve efficiency. Readmission rates are 
considered an important measure of a health system’s effectiveness, 
as they can be influenced by many factors inherent to the specific 
system.[1,7] The worldwide readmission rate varies from 10% to 25%, 
depending on the country studied.
Readmission can pose such a problem that some healthcare 
funders have introduced penalties to providers when rates are above 
a specified threshold.[3] This is done both to reduce costs and to 
improve health outcomes, as hospitals will be encouraged to provide 
better care to avoid readmissions.
Vashi et al.[8] found that although the readmission rate in their 
cohort was only 14.7%, another 9.7% of patients were what they 
called ‘treat-and-release visits’ who visited the emergency department 
within 30 days of being discharged and were treated there. These 
cases obviously impact on hospital resources and should therefore 
also be considered.[8,9]
Factors associated with an increased risk of readmission
Factors associated with an increased risk of hospital readmission 
include unavoidable sociodemographic circumstances such as age, 
gender, ethnicity, living conditions and specific diagnoses. Other risk 
factors are poor overall health and functional disability, as well as 
previous admissions within the past 6 months.
Some factors that increase readmissions are modifiable. These 
include organisational factors such as LoS, method of referral and 
discharge destination. A 2016 review[10] listed additional factors 
such as major surgery, discharging patients too soon, quantity of 
medication at discharge, failure to relay crucial information to 
the outpatient setting, and whether or not patients have a regular 
healthcare provider.[10]
Despite being a resource-limited setting with very high bed 
pressure and a high turnover rate, TBH has a 30-day readmission rate 
of 10.5%, which appears to be on a par with rates reported elsewhere 
(10 - 20%).[1,11]
Demographics. Age has been shown to be an independent risk 
factor for 30-day readmission regardless of the quality of medical care 
provided, probably owing to multiple comorbidities in the elderly 
patient population. In one study of individuals aged >50 years, 42% 
of admissions were due to chronic cardiorespiratory illnesses. In 
the study by Vashi et al.,[8] many readmissions were judged to be 
potentially preventable, mainly through improved education. [8,12] 
The present study showed a trend towards older patients being 
readmitted, with 15% aged >75 years, compared with 7% in the 
control group. Significantly, however, 71.5% of patients who were 
readmitted were aged <65 years.
Days since discharge. In the present study, 41% of patients in the 
related readmissions group were readmitted within 7 days of being 
discharged, and in both the readmitted groups 60% were readmitted 
within 14 days. These figures indicate that a high proportion of 
patients were either not fit for discharge or developed an adverse 
event necessitating readmission.
Length of stay. There was no marked difference between the 
readmitted patients and those in the control group, with median stays 
of 4 days in all three groups. In the two readmitted groups, patients 
with certain conditions such as CCF and COPD, which commonly 
led to readmission, tended to have a short LoS compared with some 
chronic conditions such as liver disease, renal disease and connective 
tissue diseases, which had a mean LoS of 5 - 12 days. Short LoS in 
conditions that carry significant morbidity could be because high bed 
pressure led to premature discharge – a leading cause for potentially 
avoidable readmission.
Diagnoses leading to readmission. As reported elsewhere, CCF 
and COPD are commonly associated with readmission.[3] In the 
present study the most common diagnosis leading to readmission 
was CCF, followed by infections, COPD, cancer and CVAs.
Appropriateness of discharge. Analysis by Auerbach and 
Kripalani[10] and Kripalani et al.[11] revealed that only 12 - 34% of 
discharge summaries reached aftercare providers by the time of 
the first post-hospitalisation appointment. In addition, discharge 
documentation was often inaccurate and lacked important information 
such as noting additional workup indicated after discharge.
Adverse events. Therapeutic errors are a major contributor to 
preventable readmission. One study showed that ~20% of patients 
were readmitted as a result of therapeutic errors.[13] Despite this, not 
all patients with treatment errors (preventable adverse effect of care) 
present to healthcare facilities. The figure could even be higher than 
that given above. Approximately 60% of such adverse events were 
determined to be potentially preventable.[13] In a 2014 review by 
Schoonover et al.,[14] 41 - 94% of patients had at least one medication 
discrepancy at different points in transition, and 29 - 38% of those 
discrepancies had the potential to cause harm.
Information is limited on the burden of serious ADRs in sub-
Saharan Africa, which has high prevalences of HIV infection and 
TB. In a study in four SA hospitals[15] the most common ADRs were 
renal impairment, hypoglycaemia, liver injury and haemorrhage; 
45% of these were considered to be preventable. Various drugs were 
implicated, including warfarin. In the present study, 33 ADRs were 
identified, of which 19 were deemed potentially avoidable. Of these, 
17 (nearly 90%) were due to warfarin toxicity. Still more perturbing 
was the fact that 6 of these 17 patients presented with warfarin 
toxicity at both their index and 30-day admissions.
Nosocomial infections. A total of 33 patients presented with 
infections at readmission. Although all were initially managed as 
nosocomial infections, only 14 of these infectious diagnoses were 
eventually attributed to nosocomial causes.
Physician-related errors. Physician errors (incorrect diagnosis 
and direct errors) were responsible for 5% of readmissions, which is 
a high figure. However, the literature shows that a training institution 
is a risk factor, as treatment of patients by junior staff members could 
lead to diagnostic errors. This factor probably contributed to the 
5% of readmissions at TBH that were due to potentially avoidable 
errors and highlights the fact that supervising consultants should be 
constantly vigilant. Close supervision of junior staff is crucial.
Thromboembolic events. These usually occur within 7 days of 
hospital discharge, in the form of deep-vein thrombosis or pulmonary 
embolism. With the advent of anticoagulation for prophylaxis they 
can easily be prevented. In the present study they accounted for 
very few readmissions (<2%) but were associated with a significant 
mortality rate (70%). We recommend increased awareness and 
commitment to preventive strategies. The well-known Padua and 
Caprini risk assessment could be used in this situation.[16,17]
Risk-stratification tools
There are various risk assessment tools available to gauge whether 
a patient is ready for discharge, the overall risk of mortality, and 
the risk of 30-day readmission. These tools stratify patients into 
categories depending on the extent of comorbidities and include 
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the LACE score, LACE+ score, PRA score (Probability of Repeated 
Admission), GAP (General Assessment of Preparedness) score and 
BOOST model.
The LACE score incorporates four parameters: length of stay of 
the index admission (L), acuity of the admission (A), comorbidities, 
incorporating the Charlston comorbidity index (C), and number of 
emergency department visits in the past 6 months (E) (Table 1).[4,18] 
A  LACE score of ≥10 provides a good threshold to differentiate 
between patients with low/medium and high risk of readmission, 
while an mLACE a score of ≥11 identifies the high-risk patient 
(Table  3). High-risk patients are 2.6 times more likely to be re ad-
mitted than those at low risk.[5,6,18]
The LACE tool has been validated to correlate well with the 
risk of 30-day readmission. According to Au et al.,[4] use of this 
model exhibited a 20.5% net reclassification improvement over the 
Charlston score alone.
In the present study, both the Charlston co-morbidity scores and 
the LACE scores were higher for the readmitted groups than for the 
control group. The LACE score was high in 59% of the patients who 
were readmitted v. only 35% of the control group. This was statistically 
significant, with a strong association between readmission and both 
the LACE and mLACE scores (p<0.001 for both, χ2 test).
Conclusions and recommendations 
The 30-day readmission rate in the TBH Department of Internal 
Medicine was calculated at 10.5%. This is an acceptable rate and 
compares favourably with published international rates of 10 - 20%.
Many patients were readmitted within the first 14 days, which 
is probably an indication of unresolved issues from their initial 
admission.
Venous thromboembolism contributed to few readmissions but 
had a high mortality rate (70%). Implementation of preventive 
strategies is urgently needed.
There was an even spread of chronic medical conditions across 
all age groups and our figures reflect a relatively young population 
with multiple comorbidities, not only due to the HIV/TB pandemic 
but also to non-communicable diseases such as cardiovascular 
conditions. In this regard, lifestyle and education need to be addressed 
at a national level.
There was a low rate of HIV testing in all groups, and we 
recommend increased uptake of HIV counselling and testing, in line 
with National Department of Health policy.
The above strategies, which can potentially decrease the 30-day 
readmission rate and ultimately improve patient care and limit costs 
related to readmissions, will require resources to be channelled into 
the areas identified.
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Table 3. LACE v. mLACE score interpretation
LACE score
Readmission 
risk mLACE score
Readmission 
risk
0 - 4
5 - 9
≥10
Low
Intermediate
High
0 - 10
≥11
Low
High
mLACE = modified LACE.
